Arcadia acquires Sanofi’s Kaopectate brand

20 March 2020 - Deborah Wilkes

Premium

Arcadia Consumer Healthcare – formerly Kramer Laboratories – has acquired US rights to Sanofi's Kaopectate brand for an undisclosed sum.

Click tags below for more information on topics:

Arcadia

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: